Brandon M. Pratt

Brandon M. Pratt

Auto-generated profile, based on publicly available information

Brandon M. Pratt

University of North Carolina at Chapel Hill

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ATAlan P. Tenney
Alan P. Tenney
SGSilvio Alessandro Di Gioia
Silvio Alessandro Di Gioia
BWBryn D. Webb
Bryn D. Webb
WCWai-Man Chan
Wai-Man Chan
EBElke de Boer
Elke de Boer
EEElizabeth C Engle
Elizabeth C Engle
Hereditary congenital facial paresis type 1 (HCFP1) is an autosomal dominant disorder of absent or limited facial movement that maps to chromosome 3q21-q22 and is hypothesized to result from facial branchial motor neuron (FBMN) maldevelopment. In the present study, we report that HCFP1 results from heterozygous duplications within a neuron-specific GATA2 regulatory region that includes two enhancers and one silencer, and from noncoding single-nucleotide variants (SNVs) within the silencer. Some SNVs impair binding of NR2F1 to the silencer in vitro and in vivo and attenuate in vivo enhancer reporter expression in FBMNs. Gata2 and its effector Gata3 are essential for inner-ear efferent neuron (IEE) but not FBMN development. A humanized HCFP1 mouse model extends Gata2 expression, favors the formation of IEEs over FBMNs and is rescued by conditional loss of Gata3. These findings highlight the importance of temporal gene regulation in development and of noncoding variation in rare mendelian disease.

26 October 2022 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
NSNancy Y. A. Sey
Nancy Y. A. Sey
BPBrandon M. Pratt
Brandon M. Pratt
Hyejung WonHyejung Won
Hyejung Won

4 February 2026 in Nature
Verified
Journal Article
Open access
PDF file
HCH. Kay Chung
H. Kay Chung
CLCong Liu
Cong Liu
ABAnamika Battu
Anamika Battu
AJAlexander Jambor
Alexander Jambor
BPBrandon M. Pratt
Brandon M. Pratt
WWWei Wang
Wei Wang
CD8 + T cells differentiate into diverse states that shape immune outcomes in cancer and chronic infection 1–4 . To define systematically the transcription factors (TFs) driving these states, we built a comprehensive atlas integrating transcriptional and epigenetic data across nine CD8 + T cell states and inferred TF activity profiles. Our analysis catalogued TF activity fingerprints, uncovering regulatory mechanisms governing selective cell state differentiation. Leveraging this platform, we focused on two transcriptionally similar but functionally opposing states that are critical in tumour and viral contexts: terminally exhausted T (TEX term ) cells, which are dysfunctional 5–8 , and tissue-resident memory T (T RM ) cells, which are protective 9–13 . Global TF community analysis revealed distinct biological pathways and TF-driven networks underlying protective versus dysfunctional states. Through in vivo CRISPR screening integrated with single-cell RNA sequencing (in vivo Perturb-seq) we delineated several TFs that selectively govern TEX term cell differentiation. We also identified HIC1 and GFI1 as shared regulators of TEX term and T RM cell differentiation and KLF6 as a unique regulator of T RM cells. We discovered new TEX term -selective TFs, including ZSCAN20 and JDP2, with no previous known function in T cells. Targeted deletion of these TFs enhanced tumour control and synergized with immune checkpoint blockade but did not interfere with T RM cell formation. Consistently, their depletion in human T cells reduces the expression of inhibitory receptors and improves effector function. By decoupling exhaustion T EX -selective from protective T RM cell programmes, our platform enables more precise engineering of T cell states, accelerating the rational design of more effective cellular immunotherapies.

18 March 2026 in Nature
Verified
Journal Article
Open access
HCH. Kay Chung
H. Kay Chung
CLCong Liu
Cong Liu
ABAnamika Battu
Anamika Battu
AJAlexander Jambor
Alexander Jambor
BPBrandon M. Pratt
Brandon M. Pratt
WWWei Wang
Wei Wang

8 January 2026 in bioRxiv
Verified
Preprint
Open access
BPBrandon M Pratt
Brandon M Pratt
GMGenevieve N Mullins
Genevieve N Mullins
NBNolan Brown
Nolan Brown
WGWilliam D Green
William D Green
JMJennifer Modliszewski
Jennifer Modliszewski
JMJ. Justin Milner
J. Justin Milner
Transcription factors (TFs) govern cell fate through coordinated gene-regulatory networks, yet the full potential of these networks to generate non-native, therapeutically advantageous cell states in vivo remains largely unexplored. We hypothesized that systematic gain-of-function (GOF) overexpression of TFs in CD8 T cells, central mediators of immune protection, could reveal latent regulatory programs capable of generating synthetic T cell states with therapeutic utility. To test this, we developed single-cell GOF sequencing (scGOF-seq), a multiplexed platform for unbiased, in vivo mapping of GOF effects on T cell fate in immunocompetent mouse models of infection and cancer. scGOF-seq uncovered unexpected regulators of T cell differentiation and accumulation, including SOX2, OCT4, and GATA2, which are normally silenced during T cell differentiation. Notably, outside its native regulatory context, supraphysiologic cMyc GOF reprogrammed CD8 T cells into a synthetic stem-effector hybrid state, enabling >5,000-fold antigen-dependent expansion and antitumor activity, contrasting sharply with its native function in driving terminal differentiation. scGOF-seq further identified TF modules that cooperate with cMyc GOF to promote robust CD8 T cell responses in solid tumors. Together, these findings establish GOF perturbation as a powerful strategy for revealing latent immune regulatory programs and engineering synthetic immune states with therapeutic potential.

11 June 2026 in Research Square
Verified
Preprint
Open access
PDF file
JMJ. Justin Milner
J. Justin Milner
BPBrandon Pratt
Brandon Pratt
GMGenevieve Mullins
Genevieve Mullins
NBNolan Brown
Nolan Brown
LRLara van Rooyen
Lara van Rooyen
HCH. Kay Chung
H. Kay Chung
CD8⁺ T cells mediate host defense and tumor immunity through specialized differentiation states, yet the regulatory programs that guide these states may also limit their functional potential. Loss-of-function studies have defined many regulators required for T cell differentiation, but they do not readily reveal regulatory activities that emerge only when transcription factors are ectopically expressed outside their native lineage, dosage, or temporal context. Here, we developed single-cell gain-of-functon(GOF) sequencing (scGOF-seq), a multiplexed platform for in vivo mapping of transcription factor overexpression in antigen-specific CD8⁺ T cells across immunocompetent models of infection and cancer. By enforcing expression of canonical T cell regulators, lineage-silenced developmental factors, and temporally restricted transcription factors, scGOF-seq uncovered unexpected in vivo activities. Developmental regulators normally silenced in T cells, including NANOG, SOX2, OCT4 and GATA2, reshaped T cell differentiation in context-dependent ways, with NANOG promoting stemness-associated phenotypes and accumulation during chronic infection. In parallel, sustained cMyc expression outside its native temporal window generated a stem-like, effector-featured state with enhanced metabolic fitness, reduced terminal exhaustion, and profound antigen-dependent expansion exceeding 5,000-fold. Importantly, cMyc GOF maintained cell-cycle checkpoint signatures and demonstrated a strong dependence on antigen presence for proliferation across the tested conditions. scGOF-seq further identified cooperating transcription factor modules that complemented cMyc-driven programs and improved T cell responses in solid tumors. These findings establish systematic GOF perturbation as a framework for uncovering latent and temporally constrained regulatory activities in CD8⁺ T cells and guiding immune-state engineering.